These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9657577)

  • 1. Deposition and clearance of inhaled 18FDG powder in patients with chronic obstructive pulmonary disease.
    Yanai M; Hatazawa J; Ojima F; Sasaki H; Itoh M; Ido T
    Eur Respir J; 1998 Jun; 11(6):1342-8. PubMed ID: 9657577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tracheobronchial mucociliary clearance and alveolar epithelial permeability measured by PET with 18FDG powder.
    Hatazawa J; Yanai M; Itoh M; Ido T; Ojima F; Takahashi T; Aikawa T; Sasaki H; Takishima T; Watanuki S
    J Comput Assist Tomogr; 1990; 14(2):175-81. PubMed ID: 2312843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a new method for simultaneously evaluating mucociliary clearance and pulmonary epithelial permeability in rabbit experiments by means of 18FDG, three-dimensional positron emission tomography and rectilinear scan.
    Ojima F; Ido T; Hatazawa J; Itoh M; Shinohara H; Watanuki S; Seo S; Kai H; Takahama K; Ishii T; Nakagawa Y; Miyata T
    Ann Nucl Med; 1998 Oct; 12(5):231-5. PubMed ID: 9839483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of a fine powder of 2-deoxy-2-[18F]fluoro-D-glucose suitable for inhalation to diagnose lung diseases by means of PET.
    Ojima F; Ido T; Takahashi T; Hatazawa J; Ito M; Sasaki H; Yanai M; Aikawa T; Takishima T; Abiko K
    Ann Nucl Med; 1989 Nov; 3(3):143-7. PubMed ID: 2641460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung clearance mechanisms in obstructive airways disease.
    Isawa T; Teshima T; Hirano T; Ebina A; Motomiya M; Konno K
    J Nucl Med; 1984 Apr; 25(4):447-54. PubMed ID: 6544816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ciprofloxacin Dry Powder for Inhalation in Patients with Non-Cystic Fibrosis Bronchiectasis or Chronic Obstructive Pulmonary Disease, and in Healthy Volunteers.
    Stass H; Nagelschmitz J; Kappeler D; Sommerer K; Kietzig C; Weimann B
    J Aerosol Med Pulm Drug Deliv; 2017 Feb; 30(1):53-63. PubMed ID: 27448179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA® Dry Powder Inhaler.
    Prime D; de Backer W; Hamilton M; Cahn A; Preece A; Kelleher D; Baines A; Moore A; Brealey N; Moynihan J
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):486-97. PubMed ID: 26372467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico evaluation of particle transport and deposition in the airways of individual patients with chronic obstructive pulmonary disease.
    Kadota K; Matsumoto K; Uchiyama H; Tobita S; Maeda M; Maki D; Kinehara Y; Tachibana I; Sosnowski TR; Tozuka Y
    Eur J Pharm Biopharm; 2022 May; 174():10-19. PubMed ID: 35351571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3D-measurement of tracheobronchial angles on inspiratory and expiratory chest CT in COPD: respiratory changes and correlation with airflow limitation.
    Onoe R; Yamashiro T; Handa H; Azagami S; Matsuoka S; Inoue T; Miyazawa T; Mineshita M
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2399-2407. PubMed ID: 30127602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substance deposition assessment in obstructed pulmonary system through numerical characterization of airflow and inhaled particles attributes.
    Lalas A; Nousias S; Kikidis D; Lalos A; Arvanitis G; Sougles C; Moustakas K; Votis K; Verbanck S; Usmani O; Tzovaras D
    BMC Med Inform Decis Mak; 2017 Dec; 17(Suppl 3):173. PubMed ID: 29297393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung deposition of aclidinium bromide from Genuair, a multidose dry powder inhaler.
    Newman SP; Sutton DJ; Segarra R; Lamarca R; de Miquel G
    Respiration; 2009; 78(3):322-8. PubMed ID: 19451700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of particle size of dry powder mannitol on the lung deposition in healthy volunteers.
    Glover W; Chan HK; Eberl S; Daviskas E; Verschuer J
    Int J Pharm; 2008 Feb; 349(1-2):314-22. PubMed ID: 17904774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the tracheobronchial clearance in patients with chronic bronchial infections by an integrated system using radioactive aerosol inhalation scintigraphy].
    Matsui Y; Amitani R; Itoh H; Kuze F
    Bull Chest Dis Res Inst Kyoto Univ; 1991 Mar; 24(1-2):12-33. PubMed ID: 1823860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ga-68 EDTA aerosols in evaluation of inhaled-particle deposition and clearance of obstructive pulmonary diseases: A pilot prospective study compared with Galligas.
    Wang ST; Bao C; Liu Q; Zhang T; Yang Y; Tian X; Zhu Z; Xu KF
    Eur J Clin Invest; 2021 Dec; 51(12):e13620. PubMed ID: 34076256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography (PET) for assessing aerosol deposition of orally inhaled drug products.
    Dolovich MB; Bailey DL
    J Aerosol Med Pulm Drug Deliv; 2012 Dec; 25 Suppl 1():S52-71. PubMed ID: 23215847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPECT/CT study of bronchial deposition of inhaled particles. A human aerosol vaccination model against HPV.
    Ilic V; Dunet V; Le Pape A; Buchs M; Kosinski M; Bischof Delaloye A; Gerber S; Prior JO
    Nuklearmedizin; 2016 Sep; 55(5):203-8. PubMed ID: 27440125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Posture on Regional Deposition of Coarse Particles in the Healthy Human Lung.
    Sá RC; Zeman KL; Bennett WD; Prisk GK; Darquenne C
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):423-31. PubMed ID: 25826480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchial airway deposition and retention of particles in inhaled boluses: effect of anatomic dead space.
    Bennett WD; Scheuch G; Zeman KL; Brown JS; Kim C; Heyder J; Stahlhofen W
    J Appl Physiol (1985); 1998 Aug; 85(2):685-94. PubMed ID: 9688747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhalation characteristics of patients when they use different dry powder inhalers.
    Azouz W; Chetcuti P; Hosker HS; Saralaya D; Stephenson J; Chrystyn H
    J Aerosol Med Pulm Drug Deliv; 2015 Feb; 28(1):35-42. PubMed ID: 24815999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of dry powder versus nebulized beta-agonist in patients with COPD who have suboptimal peak inspiratory flow rate.
    Mahler DA; Waterman LA; Ward J; Gifford AH
    J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):103-9. PubMed ID: 23745526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.